BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ical.marudot.com//iCal Event Maker
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Australia/Sydney
LAST-MODIFIED:20250410T142247Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Australia/Sydney
X-LIC-LOCATION:Australia/Sydney
BEGIN:STANDARD
TZNAME:AEST
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
DTSTART:19700405T030000
RRULE:FREQ=YEARLY;BYMONTH=4;BYDAY=1SU
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:AEDT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
DTSTART:19701004T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=1SU
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260914T030958Z
UID:1789355387654-28917@ical.marudot.com
DTSTART;TZID=Australia/Sydney:20261117T083000
DTEND;TZID=Australia/Sydney:20261119T170000
SUMMARY:Bell Potter - Healthcare Conference 2026
DESCRIPTION:Global investor sentiment towards biotechnology has strengthened materially during 2026\, with major US biotechnology indices trading back towards record levels and capital returning to innovative healthcare companies. M&A has also accelerated as major pharmaceutical companies seek to replenish their pipelines ahead of approaching patent cliffs. This improving global backdrop provides a positive lead for ASX healthcare\, with scope for investor sentiment and capital flows to strengthen as the recovery broadens.\n\nThe conference will showcase leading and emerging ASX-listed companies across biotechnology\, medical devices\, healthcare software and diagnostics. Participants will hear business updates\, growth strategies and upcoming clinical\, regulatory and commercial catalysts\, followed by opportunities for Q&A. Supported by Bell Potter’s deep healthcare expertise across research and capital markets\, the conference provides a timely opportunity to connect with companies positioned to benefit from the sector’s next phase of growth.
END:VEVENT
END:VCALENDAR